Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA).
This study is enrolling at both Buffalo & Rochester locations.
COVID Vaccine
Age Range:
50 to 64
Gender:
Male and Female
Location:
Buffalo, New York
About the Study
- Single study vaccination on Day 0, then health check-ins through ~6 months to monitor safety and effectiveness.
- Visit schedule: a screening visit and a vaccination visit, with scheduled follow-ups through 6 months (your exact office and check-in schedule will be confirmed at screening).
Qualifications
- Age 50 to <65 at the time of vaccination.
- Generally healthy (not considered at high risk for severe COVID-19).
* Other qualifications may apply.
FEATURED STUDIES
Rochester Clinical Research is screening healthy adults ages 18 to 49 for an upcoming smallpox/mpox vaccine study at both our […]
Rochester Clinical Research is now enrolling adults 50-64 years old for a study evaluating an updated mRNA COVID-19 vaccine.
Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA). This study is enrolling […]
Rochester Clinical Research is actively recruiting participants aged 45+ for a clinical trial study testing an investigational medication designed to […]
Researchers are studying an investigational medication to see how effective it may be in slowing the Progression of Parkinson’s Disease. […]
We’re preparing for an upcoming research opportunity that may focus on people who smoke and are interested in learning more […]